# Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes

> **NCT00725036** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 305 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** inhaled human insulin
- **DRUG:** insulin aspart
- **DRUG:** insulin NPH

## Key facts

- **NCT ID:** NCT00725036
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09-02
- **Primary completion:** 2004-12-14
- **Final completion:** 2004-12-14
- **Target enrollment:** 305 (ACTUAL)
- **Last updated:** 2017-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00725036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00725036, "Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT00725036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*